Press Release Doğuş Technology and Doğuş Construction Participate in ConteQ Expo 2024 with Innovative Projects 15 September 2024
Press Release First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera’s Ability to Predict Overall Survival 14 September 2024
Press Release Masimo Partners with Qualcomm to Develop Next-Generation Smartwatch Reference Platform for Original Equipment Manufacturers 14 September 2024
Press Release Incyte’s CDK2 Inhibitor INCB123667 Shows Promising Evidence of Clinical Activity in Patients with Advanced Solid Tumors, Notably Ovarian Cancer 14 September 2024
Press Release Dongfeng Embarks on a New Journey in Europe, Various New Products Debuted Offer Diversified Mobility Options 14 September 2024
Press Release KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination With Transarterial Chemoembolization Significantly Improved Progression-Free Survival Compared to TACE Alone in Patients With Unresectable, Non-Metastatic Hepatocellular Carcinoma 14 September 2024
Press Release Merck’s KEYTRUDA® (pembrolizumab) Plus Chemoradiotherapy (CRT) Reduced Risk of Death by 33% Versus CRT Alone in Patients With Newly Diagnosed High-Risk Locally Advanced Cervical Cancer 14 September 2024
Press Release Incyte’s Retifanlimab (Zynyz®) Extends Progression-Free Survival in Patients with Squamous Cell Anal Carcinoma (SCAC); Data Featured at ESMO 2024 Presidential Symposium 14 September 2024
Press Release Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia 14 September 2024
Press Release University of Phoenix Continues to Empower Young Learners at Hackathon Jr. Event 14 September 2024
